SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Merck -- Ignore unavailable to you. Want to Upgrade?


To: Ibexx who wrote (1110)12/10/1998 7:16:00 PM
From: Ardner Cheshire, Jr.  Read Replies (1) | Respond to of 1580
 
Thread, don't you just love posters who suddenly appear after a stock takes a dive and tell you that they, the poster, never owned the stock?

BTW, Ibexx, Merck is up 38% YTD and 244% (excluding dividends) since March 1995. Also, MRK has a PE less than PFE, WLA, and LLY, and the same PE as BMY's. MRK is no more in "nosebleed territory" than any other drug company.